James S. J. Manuso - 18 Nov 2021 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Jeffrey Kuras, by Power of Attorney
Issuer symbol
IRD
Transactions as of
18 Nov 2021
Net transactions value
+$7,000
Form type
4
Filing time
22 Nov 2021, 15:01:42 UTC
Previous filing
09 Jun 2021
Next filing
24 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Purchase $7,000 +2,000 +14% $3.50 16,570 18 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $3.4966 to $3.4998. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.